Is Exosome Therapy FDA-Approved?

No. As of 2026, the U.S. Food and Drug Administration (FDA) has not approved any exosome product. No approval exists for therapeutic use in humans.

Exosome therapies offered in clinics today are investigational. The FDA has specifically warned about products marketed with claims of “FDA registration” or regulatory compliance for injection. Those claims are misleading.

That doesn’t mean exosome research isn’t real or promising. It does mean patients need to understand what they’d be agreeing to. Know that before pursuing it.

What This Means

“Not FDA-approved” does not always mean unsafe or worthless. It means no exosome product has completed the FDA’s formal review process. That review covers whether a product is safe and effective for a specific condition.

Exosomes are tiny, cell-free particles released by cells, including stem cells. They carry proteins and genetic signals. Those signals are involved in tissue repair and cell-to-cell communication. Early research is genuinely promising.

Encouraging lab and early clinical data is not the same as regulatory approval. Clinics that imply otherwise are not being straight with patients.

Candidacy

No exosome product is FDA-approved for any indication. So there is no official “candidate” profile, the way there would be for an approved drug.

In practice, physicians discuss exosome-based options in a personal conversation. That conversation covers musculoskeletal, orthopedic, or soft-tissue concerns. Standard care has been tried or considered first.

Patients usually not considered good candidates include those who:

• Are pregnant
• Have active infections
• Have a history of certain cancers
• Are seeking exosome products in place of a workup for a serious or urgent medical condition

A responsible practice should say so plainly.

Clinical Evaluation

A thorough workup should look the same as for any orthobiologic or regenerative option. It usually includes:

• A detailed history
• A physical exam targeted to the area of concern
• Imaging (X-ray, ultrasound, or MRI) when it would change the treatment plan

Physicians should also review three more things:

• Prior treatments tried
• Red-flag symptoms that warrant referral to a specialist
• Realistic goals for what the patient wants to achieve

Some clinics offer exosome therapy without this kind of personal workup. That skips a step that matters.

Available Options

Exosome injections are one option among several. Standard, well-established options include:

• Physical therapy
• Activity modification
• Oral or topical anti-inflammatory medication
• Corticosteroid injections
• Surgical referral, when appropriate

Patients may hear about other orthobiologic options. Two common ones are platelet-rich plasma (PRP) and certain stem cell-based therapies. Each carries its own evidence base and its own regulatory questions.

PRP is usually minimally manipulated. FDA policy handles it differently than exosome products. Stem cell therapy in Florida is now addressed separately under state law.

None of these options should be presented as guaranteed to work. A good discussion also includes doing nothing and watching.

Benefits, Limitations & Risks

Benefits

Proponents point to preclinical and early-stage findings. Those findings suggest exosomes may do three things:

• Support tissue repair
• Modulate inflammation
• Communicate regenerative signals between cells

Those are real research findings.

Limitations and Risks

The limitations are just as real:

• Exosome products are not standardized across manufacturers
• Dosing and purity vary widely
• There is no FDA-cleared product to compare against

On risk, the FDA has documented serious adverse events tied to unapproved exosome products. Those events include infections and hospitalization. They follow a 2019 public safety alert about patients harmed by products marketed as containing exosomes.

Any clinic that waves away these risks, or promises a specific outcome, is not being honest with you.

What the Evidence Shows

Current evidence does establish one thing. Exosomes play a real biological role in cell signaling and tissue repair. Early studies in wound healing, tendon injury, and cardiac tissue are worth continued research.

What the evidence does not establish is safety and effectiveness for a specific human condition. No exosome product on the market has met that bar outside a formal clinical trial.

That gap is exactly what the FDA’s warnings are about: promising biology on one side, proven and approved treatment on the other. It’s the single most important thing to understand before considering this therapy.

Recovery / Next Steps

Exosome products vary by manufacturer, and there is no standardized, approved protocol. So “typical recovery” can’t be stated reliably here. It can be for an FDA-approved procedure.

Are you weighing an injection-based option of any kind? Ask about:

• Expected downtime
• Activity restrictions
• A realistic timeline for noticing any change

Get that answer in writing, not just verbally.

Orlando Considerations

Florida’s 2025 Stem Cell Therapy Act gives Florida-licensed physicians a specific, regulated pathway. Under it they may offer certain non-FDA-approved stem cell therapies in three areas:

• Orthopedics
• Wound care
• Pain management

The law requires mandatory advertising disclosures and written informed consent.

That law is written narrowly around stem cell products, though. Its definition of covered products excludes “secreted or extracted human products.” That language describes what exosomes are.

In plain terms: Florida’s newer stem cell law does not appear to create a state-level safe harbor for exosome products. It does create one for stem cells. Exosome therapy offered in Orlando is still governed mainly by the same federal FDA rules described above.

Ask any local clinic directly which regulatory framework applies to the product being offered. Ask whether any framework applies at all.

Frequently Asked Questions

Is exosome therapy the same as stem cell therapy?

No. Exosomes are cell-free particles released by cells. Stem cell therapy involves live cells themselves. The two are regulated somewhat differently. Florida’s 2025 stem cell law does not clearly cover exosome products the way it covers stem cells.

Can a clinic legally offer exosome therapy if it’s not FDA-approved?

Physicians can discuss exosome-based options as investigational. Two situations raise real regulatory and safety concerns:

• A product marketed with FDA-approval claims
• A product offered outside a legitimate FDA Investigational New Drug (IND) application and IRB oversight

What should I ask before considering exosome therapy?

Ask four questions:

• Is the product part of an FDA-registered clinical trial with an IND number?
• Who manufactures it, and under what quality standards?
• What specific risks apply to you?
• What does the realistic (not promised) evidence support for your condition?

Are there FDA-approved alternatives?

Yes. Established, FDA-regulated pathways include:

• Physical therapy
• Anti-inflammatory medications
• Corticosteroid injections
• Surgery

Which one fits depends on the condition. All of them should be part of any honest conversation about options.

Is exosome therapy covered by insurance?

No. Exosome therapy is investigational and not FDA-approved for any specific condition. Insurance and Medicare do not cover it. It is usually offered on a cash-pay basis.

References

Florida Statutes. (2025). Stem cell therapy, Fla. Stat. § 458.3245. The Florida Senate.

Roszkowski, S. (2024). Therapeutic potential of mesenchymal stem cell-derived exosomes for regenerative medicine applications. Clinical and Experimental Medicine, 24, Article 46. https://doi.org/10.1007/s10238-023-01282-z

Tiner, S. (2021, July 22). Beyond stem cells, regenerative medicine finds exosomes. Mayo Clinic News Network.

U.S. Food and Drug Administration. (2019, December 9). Public safety alert due to marketing of unapproved stem cell and exosome products.

U.S. Food and Drug Administration. (2020, July 22). Consumer alert on regenerative medicine products including stem cells and exosomes.

Last medically reviewed: August 18, 2026.

Related reading

• Are Exosomes FDA Approved? What Patients Should Know
• Does Microneedling With Exosomes Actually Work?
• Exosome Therapy vs. Stem Cell Therapy: What's the Difference?
• Is Stem Cell Therapy Legal in the U.S.?

More questions answered on the PrimeCell patient blog, or see frequently asked questions.

Related services at PrimeCell

PrimeCell is a physician-led practice in Orlando. Candidacy for any procedure is determined at an in-person evaluation.